“Is it not to share your food with the hungry, and to provide the poor wanderer with shelter – when you see the naked, to clothe them, and not to turn away from your own flesh and blood?”

The pharmaceutical industry is embracing a more patient-centric approach throughout the drug development and commercialization value chain. As patients become more involved in their care and evaluate options available to them, pharma organizations are working on new care models to work more closely with the patients and not just with physicians, healthcare organizations and payers.

The U.S. Department of Health and Human Services (HHS) is considering proposing a plan that has many moving parts, one of which could potentially take the price that Medicare pays out to providers for Medicare Part B drugs and turn it on its head.

The talent and tenacity of immigrants can help drive the life sciences industry into the future, if we have the will and the wisdom to encourage it.